Evaluator Transparency List

We evaluate practices, not people. See Methodology

Open-ended monitoring in low-risk cases Avoid

First listed: Aug 17, 2025 • Last review: Aug 17, 2025

Why: Extends surveillance without evidence of benefit; raises cost and burden.

Evidence: Documented cases and expert commentary; see sources linked in individual entries.

What would change this: Clear, published criteria aligning monitoring duration to risk.

Employer-driven influence on medical recommendations Avoid

First listed: Aug 17, 2025 • Last review: Aug 17, 2025

Why: Conflicts with independent medical judgment and patient privacy.

What would change this: Firewalls between employer interests and evaluator decisions.

Time-limited step-down monitoring with objective milestones Consider

First listed: Aug 17, 2025 • Last review: Aug 17, 2025

Why: Balanced approach if milestones are evidence-based and transparent.

What would improve: Publish criteria and shorten default durations.

Individualized care plans based on documented risk Recommend

First listed: Aug 17, 2025 • Last review: Aug 17, 2025

Why: Aligns burden and oversight with clinical indicators and recovery stability.

Maintain: Keep criteria public; allow right-of-reply for corrections.

Submit a Concern

We verify patterns—not individual claims—and publish anonymously. No PHI, please.